Literature DB >> 3655362

The primary role of murine bone marrow in the production of natural killer cells. A cytokinetic study.

S B Pollack1, C Rosse.   

Abstract

The normal steady state production of natural killer (NK) cells in the bone marrow and spleen was characterized with cytokinetic technics. We developed a protocol to enrich for NK cells in bone marrow and demonstrate that target binding can be used as a criterion for marrow NK cells if nonspecifically "sticky" cells are eliminated. The selected population of B cell-depleted bone marrow lymphoid cells was comprised mainly of lymphocytes, of which 80% were NK-1.1+. B cell-depleted bone marrow lymphocytes that bound to YAC-1 could be characterized as two populations on the basis of morphology and proliferative status: large, proliferating target-binding cells (TBC), of which 25% were in S phase of the mitotic cycle, and small postmitotic TBC. Pulse and chase studies indicated that the small TBC in bone marrow were derived from an immediate proliferating precursor, presumably the large TBC, which were, in turn, derived from a precursor population that was more rapidly proliferating. In contrast, few if any splenic TBC were labeled after a 30-min pulse with [3H]TdR and significant numbers of labeled TBC did not appear in the spleen until 2 or more days after the pulse label. Surprisingly, some of the splenic TBC were relatively long lived and survived 2 mo or longer. These studies are the first to directly characterize the production of NK cells in situ in normal marrow. We demonstrate that the marrow is the primary site of production of NK cells and that little, if any, proliferation of NK cells occurs in the periphery of unstimulated mice. The data suggest the existence in the bone marrow of at least three compartments in the NK lineage: a rapidly proliferating NK precursor population, a less rapidly proliferating population of large TBC, and a population of small postmitotic TBC.

Entities:  

Mesh:

Year:  1987        PMID: 3655362

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance.

Authors:  Samuel A LoCascio; Tatsuaki Morokata; Meredith Chittenden; Frederic I Preffer; David M Dombkowski; Giovanna Andreola; Kerry Crisalli; Tatsuo Kawai; Susan L Saidman; Thomas R Spitzer; Nina Tolkoff-Rubin; A Benedict Cosimi; David H Sachs; Megan Sykes
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

Review 2.  Non-adaptive cellular immune responses as studied in euthymic and athymic nude rats. Spontaneous rejection of allogeneic lymphoid cell grafts by natural killer (NK) cells.

Authors:  B Rolstad; S Fossum
Journal:  Anat Embryol (Berl)       Date:  1990

3.  Natural health products, modulation of immune function and prevention of chronic diseases.

Authors:  Pierre S Haddad; Georges A Azar; Simon Groom; Michel Boivin
Journal:  Evid Based Complement Alternat Med       Date:  2005-10-20       Impact factor: 2.629

4.  Cooperative effects of colony-stimulating factor 1 and recombinant interleukin 2 on proliferation and induction of cytotoxicity of macrophage precursors generated from mouse bone marrow cell cultures.

Authors:  H Li; R Schwinzer; M Baccarini; M L Lohmann-Matthes
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

5.  Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation.

Authors:  M Sykes; M W Harty; F M Karlhofer; D A Pearson; G Szot; W Yokoyama
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

6.  A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors.

Authors:  A Rolink; E ten Boekel; F Melchers; D T Fearon; I Krop; J Andersson
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

Review 7.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.